DIA Biosimilars 2013

Horizon Discovery

Horizon Discovery, AstraZeneca collaborate on oncology drug discovery

Monday, April 22, 2013 01:54 PM

Horizon Discovery, a provider of research tools to support translational genomics research, and AstraZeneca have entered into an exclusive collaboration and license agreement to explore Horizon's first-in-class kinase target program, HD-001, as a means of developing novel therapies for multiple cancer types.

More... »

Cenduit: Now with Patient Reminders

Crown Bioscience, Horizon Discovery form two-year agreement for in vivo drug discovery model development

Wednesday, April 3, 2013 11:16 AM

Crown Bioscience, a global drug discovery and development service company, and Horizon Discovery, a provider of research tools to support the development of personalized medicines, have signed an exclusive two year collaboration agreement. The relationship is a continuation of a previous collaboration between the two companies.

More... »

CRF Health – eCOA Forum

Horizon, Boehringer Ingelheim enter oncology research service collaboration

Monday, January 14, 2013 11:36 AM

Horizon Discovery, a provider of research tools to support the development of personalized medicines has signed a research service collaboration agreement with Germany-based Boehringer Ingelheim.

More... »

CenterWatch Drugs in Clinical Trials Database Library. Drug intelligence right at your fingertips.
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

September 30

Novartis-Walgreens pilot study blurring the line between retail pharmacy, investigative site

CISCRP to launch traveling science museum exhibit to demystify clinical trial participation

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

October

New growth and decline in Asia clinical trials
South Korea, Japan, China see big growth in 1572s, while India posts huge drop

Harnessing Big Data to transform clinical trials
From protocol to patient recruiting, data analytics can yield valuable insights

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

September

Sponsors look to collaborate on comparator drugs
Co-therapies, comparators are in 60% of studies, cost $25m per company a year

Early adopters implement risk-based monitoring pilot programs
Experiments aim to offer long-term solutions, despite short-term uncertainties

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs